Martin Dow Pharmaceuticals (Pak) Ltd

Sitaphage 50 mg / 500 mg tablets

Sitaphage 50 mg / 500 mg tablets

Regular price Rs.213.78
Regular price Sale price Rs.213.78
Sale Sold out
Shipping calculated at checkout.

Product overview:

Product form: tablets

Pack size: 2 x 7's tablets

Manufactured by: MartinDow

Priscription: Yes

Product Details:

Sitaphage 50 mg / 500 mg tablets are a combination medication designed for the management of Type II diabetes. The active ingredients help regulate blood sugar levels, improving the body's response to insulin while simultaneously reducing glucose production in the liver. This combination is particularly beneficial for adult patients with Type II diabetes, helping them achieve better glycemic control.

Purposes:

  • Type II Diabetes: Sitaphage is used to manage blood sugar levels in adult patients with Type II diabetes, either alone or in combination with other treatments like sulphonylureas or insulin.
  • Adjuvant Therapy: Especially helpful in managing insulin-dependent diabetes in overweight patients.

How To Use:

  • Administration: Take the tablet by mouth with a glass of water.
  • Timing: It is recommended to take this medication with or without food, preferably during meals.
  • Dosage: Follow your doctor’s prescribed dosage exactly. Do not skip or change the dosage unless instructed.
  • Consistency: Take this medication at the same time every day to maintain consistent blood sugar control.

Expert Advice:

  • Hydration: Drink plenty of fluids to avoid dehydration.
  • Compliance: Do not stop taking the medication without consulting your doctor. Consistency is key to managing diabetes.
  • No Sharing: This medication is prescribed specifically for you. Do not share it with others.
  • Consultation: Immediately seek medical attention if you experience any severe side effects or reactions.

Warnings:

Pregnancy:
Sitaphage is not recommended during pregnancy. Pregnant women should consult their doctor for safer alternatives.

Lactation:
Nursing mothers are advised against using Sitaphage. Consult your healthcare provider for advice on safe diabetes management during lactation.

Driving:
This medication does not usually impair driving ability. However, if you feel dizzy or experience any symptoms that affect your focus, avoid driving and consult your doctor.

Liver:
Patients with liver impairment should use this medication cautiously and consult a healthcare professional for dose adjustments.

Kidney:
Use Sitaphage with caution in patients with kidney issues, as it may require dose modification. Regular monitoring of kidney function is advised.

Alcohol:
Excess alcohol consumption while using this medication can increase the risk of lactic acidosis. Limit or avoid alcohol intake during treatment.

Adverse Effects:

Common side effects associated with Sitaphage include:

  • Gastrointestinal upset (nausea, vomiting, diarrhea)
  • Taste disturbance
  • Abnormal liver function tests
  • Hepatitis (inflammation of the liver)
  • Skin reactions
  • Reduced vitamin B12 absorption
  • Rarely, lactic acidosis (a potentially serious condition caused by the buildup of lactic acid in the bloodstream)

If you experience any severe or unusual side effects, consult your doctor immediately.

Cautions:

  • Lactic Acidosis Risk: Patients should be assessed for the risk of lactic acidosis before starting treatment. If metabolic acidosis is suspected, discontinue the medicine and seek medical attention.
  • Kidney Monitoring: Regular kidney function tests are recommended at least annually.
  • Surgery: Stop taking Sitaphage for 48 hours before and after any elective surgery.
  • Metabolic Acidosis: In the case of suspected metabolic acidosis, immediate discontinuation is necessary.

Contraindications:

Sitaphage is contraindicated in patients with:

  • Diabetic ketoacidosis or precoma
  • Severe kidney or liver impairment
  • Conditions that predispose patients to kidney impairment
  • Cardiac or respiratory failure
  • Recent myocardial infarction (heart attack)
  • Chronic alcoholism
  • Those receiving iodinated contrast materials for imaging procedures
View full details

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)